Nuceiva/Anti-Wrinkle Injections

Nuceiva, available at Gates Medispa, is a cutting-edge cosmetic treatment that delivers remarkable results in the realm of facial aesthetics. This advanced injectable solution is formulated with precision and expertise to provide clients with a natural and refreshed appearance. Nuceiva, often referred to as the "next-generation Botox," is designed to reduce the appearance of fine lines and wrinkles, helping individuals achieve a more youthful and rejuvenated look. Our highly skilled team at Gates Medispa is proud to offer this innovative treatment, ensuring that each patient receives personalized care and exceptional outcomes. With Nuceiva, you can experience a revitalized and youthful glow, enhancing your confidence and radiance like never before.

Nuceiva Treatment Areas

Forehead Lines

Crow's Feet

Frown Lines ("Elevens")

Plus More!

FAQ

  • How do Nuceiva/anti-wrinkle injections work?

    Nuceiva/anti-wrinkle injections target the repeated muscle contractions from frowning, squinting, smiling and raising the eyebrows over the years. Our trained injector will inject these muscles to temporarily reduce muscle activity. You will begin to notice a visible smoothing of the frown lines between your brows, your crow’s feet lines and your forehead lines.

    Treatment requires minimal downtime. So you can return to your daily routine almost immediately after your treatment.

  • When will I see results? How long will my results last?

    You may begin to notice results within 24 to 48 hours, with full results showing after about 2 weeks. On average, your results should last 3-4 months. Remember that results vary from patient to patient, so our trained injectors and skin care specialists will plan your next appointment based on your results and aesthetic goals.

  • What's the expected downtime?

    Treatment requires minimal downtime. Other than avoiding lying or looking down for a few hours post-treatment, you may return to your daily routine immediately after you leave our clinic.